Grundläggande statistik
| LEI | 529900NY3F5Q2NWPUZ42 |
| CIK | 851520 |
SEC Filings
SEC Filings (Chronological Order)
| May 8, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 3, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC |
|
| April 30, 2026 |
Exponent Reports First Quarter 2026 Financial Results EXHIBIT 99.1 Exponent Reports First Quarter 2026 Financial Results MENLO PARK, Calif., April 30, 2026 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2026 ended April 3, 2026. “Exponent delivered double-digit growth in revenues and earnings during the first quarter, reflecting the strength of our multidisciplinary portfolio and |
|
| April 30, 2026 |
EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend for Q2 2026 and Increases Stock Repurchase Authorization by $50 Million MENLO PARK, Calif., April 30, 2026 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.31 per share of common stock to be paid on June 18, 2026 to all common stockholders of record as |
|
| April 30, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2026 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| April 21, 2026 |
2025 AnnualReportDear Fellow Shareholders, Exponentdelivereda strongfinish to 2025, reflectingthe depthofour expertise, theresilienceofourdiversified portfolio,and thegrowing relevanceofour workas clientsconfrontnewlevelsoftechnological complexity. |
|
| April 20, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| April 6, 2026 |
EXHIBIT 99.1 Exponent Elevates John Pye to President and Eric Anderson to CFO Reporting to Catherine Corrigan, CEO; Rich Schlenker to Remain as Executive VP and to Stand for Election to Board of Directors MENLO PARK, Calif., April 06, 2026 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO), a leading engineering and scientific consulting firm, today announced its appointment of John Pye to President |
|
| April 6, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 6, 2026 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| February 27, 2026 |
Note 14: Miscellaneous Income, Net Note 15: Industry and Client Concentration Risk UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended January 2, 2026. OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONENT, INC. (Exact name |
|
| February 27, 2026 |
Exhibit 21.1 SUBSIDIARIES OF THE COMPANY State or Other Jurisdiction of Incorporation or Subsidiary Incorporation or Organization Exponent Consulting (Canada) Inc. Canada Exponent Consulting PTE. Ltd. Singapore Exponent International Engineering and Scientific Consulting Limited Ireland Exponent International GmbH Germany Exponent International Ltd. United Kingdom Exponent Limited Hong Kong Expone |
|
| February 27, 2026 |
Exponent, Inc. Policy on Transactions in Company Securities Exhibit 19.1 Exponent, Inc. Policy on Transactions in Company Securities and procedures governing “Insider Trading” (as amended through February 17, 2026) 1. Purpose of Policy This Policy describes the responsibility of employees, officers and members of the board of directors of EXPONENT, INC. (the "Company") to comply with the laws governing securities transactions. In addition, the Company has |
|
| February 5, 2026 |
Exponent Increases Quarterly Dividend Payment from $0.30 to $0.31 per Share for Q1 2026 EXHIBIT 99.2 Exponent Increases Quarterly Dividend Payment from $0.30 to $0.31 per Share for Q1 2026 MENLO PARK, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has raised its quarterly cash dividend from $0.30 to $0.31 per share of common stock. The quarterly cash dividend of $0.31 per share of common stock is to be paid on March |
|
| February 5, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2026 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| February 5, 2026 |
Exponent Reports Fourth Quarter and Fiscal Year 2025 Financial Results EXHIBIT 99.1 Exponent Reports Fourth Quarter and Fiscal Year 2025 Financial Results MENLO PARK, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2025 ended January 2, 2026. “We delivered a strong finish to 2025 reflecting the strength, diversification, and resilience of our portfolio,” stated Dr. Catherin |
|
| November 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 3, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, I |
|
| October 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2025 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| October 30, 2025 |
Exponent Reports Third Quarter of Fiscal Year 2025 Financial Results EXHIBIT 99.1 Exponent Reports Third Quarter of Fiscal Year 2025 Financial Results MENLO PARK, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the third quarter of fiscal year 2025 ended October 3, 2025. “Exponent delivered a strong third quarter, achieving double digit net revenue growth that reflects the strength of our diversified portf |
|
| October 30, 2025 |
EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend for Q4 2025 and Increases Stock Repurchase Authorization by $100 Million MENLO PARK, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share of common stock to be paid on December 19, 2025 to all common stockholders of record |
|
| September 15, 2025 |
144 0001552213 XXXXXXXX LIVE 0000851520 EXPONENT, INC. 000-18655 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 6503269400 CATHERINE CORRIGAN Director Officer Common Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004 4905 343595.25 50501135 09/15/2025 NASDAQ Common 09/15/2025 Exercise of Stock Options Issuer N 4905 09/15/2025 Cash N 10b5-1 Sales f |
|
| August 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 4, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC. |
|
| July 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2025 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| July 31, 2025 |
Exponent Declares Regular Quarterly Dividend for Q3 2025 EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend for Q3 2025 MENLO PARK, Calif., July 31, 2025 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share of common stock to be paid on September 19, 2025, to all common stockholders of record as of September 5, 2025. Exponent has paid, and expects to |
|
| July 31, 2025 |
Exponent Reports Second Quarter 2025 Financial Results EXHIBIT 99.1 Exponent Reports Second Quarter 2025 Financial Results MENLO PARK, Calif., July 31, 2025 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter of fiscal year 2025 ended July 4, 2025. “Second quarter revenues were flat but exceeded expectations, reflecting our team’s disciplined execution and resilience in this dynamic environment,” st |
|
| June 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2025 Exponent, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 0-018655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 4, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC |
|
| May 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2025 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) ( |
|
| May 1, 2025 |
Exponent Declares Regular Quarterly Dividend for Q2 2025 EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend for Q2 2025 MENLO PARK, Calif., May 01, 2025 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share of common stock to be paid on June 20, 2025 to all common stockholders of record as of June 6, 2025. Exponent has paid, and expects to continue to |
|
| May 1, 2025 |
Exponent Reports First Quarter 2025 Financial Results EXHIBIT 99.1 Exponent Reports First Quarter 2025 Financial Results MENLO PARK, Calif., May 01, 2025 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2025 ended April 4, 2025. “Exponent’s first quarter results exceeded expectations, reinforcing both the resilience of our diversified business model and the value we deliver,” said |
|
| April 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| April 21, 2025 |
2024 AnnualReportDearFellow Shareholders, Exponent’s resilience wasonfulldisplay in2024,demonstrating thestrengthofourdiversifiedservicesportfolio andouruniquely brilliant, collaborativeanddedicatedteam. |
|
| April 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 ☒ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended January 3, 2025. OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONENT, |
|
| February 28, 2025 |
Certificate of Amendment of Restated Certificate of Incorporation dated January 30, 1998. Exhibit 3.1(ii) STATE OF DELAWARE SECRETARY OF STATE DIVISION OF CORPORATIONS FILED 04:30 PM 01/30/1998 981039836 - 2195846 CERTIFICATE OF AMENDMENT OF RESTATED CERTIFICATE OF INCORPORATION OF THE FAILURE GROUP, INC. THE FAILURE GROUP, INC., a corporation organized and existing under and by virtue of General Corporation Law of the State of Delaware (the "General Corporation Law"). does hereby cert |
|
| February 28, 2025 |
Exhibit 21.1 SUBSIDIARIES OF THE COMPANY State or Other Jurisdiction of Incorporation or Subsidiary Incorporation or Organization Exponent Consulting (Canada) Inc. Canada Exponent Consulting PTE. Ltd. Singapore Exponent International Engineering and Scientific Consulting Limited Ireland Exponent International GmbH Germany Exponent International Ltd. United Kingdom Exponent Limited Hong Kong Expone |
|
| February 28, 2025 |
EXHIBIT 107 Calculation of Filing Fee Table Form S-8 (Form Type) Exponent, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule (2) Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee (3) Equity Common Stock $0.001 p |
|
| February 28, 2025 |
Exhibit 19.1 Exponent, Inc. Policy on Transactions in Company Securities and procedures governing “Insider Trading” (as amended through October 1, 2016) 1. Purpose of Policy This Policy describes the responsibility of employees, officers and members of the board of directors of EXPONENT, INC. (the "Company") to comply with the laws governing securities transactions. In addition, the Company has es |
|
| February 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 EXPONENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 77-0218904 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 149 Commonwealth Drive, Menlo Park, California 94025 (Address of Principa |
|
| February 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended January 3, 2025. OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONENT, INC. (Exact name |
|
| February 28, 2025 |
Exponent, Inc. Incentive Compensation Recovery Policy Exhibit 97.01 EXPONENT, INC. 2023 Clawback Policy Effective October 2, 2023 Purpose As required pursuant to the listing standards of the Nasdaq Stock Market LLC (the “Stock Exchange”), Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule 10D-1 under the Exchange Act, the Board of Directors (the “Board”) of Exponent, Inc. (the “Company”) has adopted this 202 |
|
| February 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2025 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| February 6, 2025 |
Exponent Increases Quarterly Dividend Payment from $0.28 to $0.30 per Share for Q1 2025 EXHIBIT 99.2 Exponent Increases Quarterly Dividend Payment from $0.28 to $0.30 per Share for Q1 2025 MENLO PARK, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has raised its quarterly cash dividend from $0.28 to $0.30 per share of common stock. The quarterly cash dividend of $0.30 per share of common stock is to be paid on March |
|
| February 6, 2025 |
Exponent Reports Fourth Quarter and Fiscal Year 2024 Financial Results EXHIBIT 99.1 Exponent Reports Fourth Quarter and Fiscal Year 2024 Financial Results MENLO PARK, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2024 ended January 3, 2025. "Our fourth quarter results exceeded expectations, capping off a solid year that demonstrated the resilience of the business. With a |
|
| November 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 27, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT |
|
| November 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2024 EXPONENT, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| October 24, 2024 |
Exponent Reports Third Quarter of Fiscal Year 2024 Financial Results EXHIBIT 99.1 Exponent Reports Third Quarter of Fiscal Year 2024 Financial Results MENLO PARK, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the third quarter of fiscal year 2024 ended September 27, 2024. “For the third consecutive quarter Exponent has delivered significantly improved utilization year over year, reflecting our ongoing fo |
|
| October 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2024 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| October 24, 2024 |
Exponent Declares Regular Quarterly Dividend for Q4 2024 EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend for Q4 2024 MENLO PARK, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.28 per share of common stock to be paid on December 20, 2024 to all common stockholders of record as of December 6, 2024. Exponent has paid, and expects to co |
|
| October 3, 2024 |
EXPO / Exponent, Inc. / Neuberger Berman Group LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 16)* EXPONENT INC (Name of Issuer) Common (Title of Class of Securities) 30214U102 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is |
|
| August 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 28, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC |
|
| July 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2024 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| July 25, 2024 |
Exponent Reports Second Quarter 2024 Financial Results EXHIBIT 99.1 Exponent Reports Second Quarter 2024 Financial Results MENLO PARK, Calif., July 25, 2024 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter of fiscal year 2024 ended June 28, 2024. “We are pleased with the outcomes of efforts to align our operating model with market demand, evidenced by net income growth of 14% and expanded EBITDA1 |
|
| July 25, 2024 |
Exponent Declares Regular Quarterly Dividend for Q3 2024 EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend for Q3 2024 MENLO PARK, Calif., July 25, 2024 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.28 per share of common stock to be paid on September 20, 2024, to all common stockholders of record as of September 6, 2024. Exponent has paid, and expects to |
|
| June 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 19, 2024 EXPONENT, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| June 24, 2024 |
Exhibit 10.1 June 5, 2024 Arizona State Land Department 1110 W Washington Street Phoenix, Arizona 85007 Attention: James Perry Deputy State Land Commissioner Re: Notice of election to extend the Lease term under that certain Commercial Lease No. 03‑53542 dated January 17, 1998 (the “Lease”), by and between Failure Analysis Associates, Inc., as predecessor-in-interest to Exponent of Delaware Inc., |
|
| June 11, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 06, 2024 EXPONENT, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 29, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, IN |
|
| April 25, 2024 |
Exponent Reports First Quarter 2024 Financial Results EXHIBIT 99.1 Exponent Reports First Quarter 2024 Financial Results MENLO PARK, Calif., April 25, 2024 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2024 ended March 29, 2024. “Exponent delivered better than expected results in the first quarter, as we grew revenues before reimbursements 7% and expanded earnings per share year |
|
| April 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2024 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| April 25, 2024 |
Exponent Declares Regular Quarterly Dividend for Q2 2024 EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend for Q2 2024 MENLO PARK, Calif., April 25, 2024 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.28 per share of common stock to be paid on June 21, 2024 to all common stockholders of record as of June 7, 2024. Exponent has paid, and expects to continue |
|
| April 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| April 22, 2024 | ||
| April 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| April 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 ☒ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 29, 2023. OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONEN |
|
| April 10, 2024 |
EXPO / Exponent, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0013-exponentinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 14)* Name of issuer: Exponent Inc Title of Class of Securities: Common Stock CUSIP Number: 30214U102 Date of Event Which Requires Filing of this Statement: March 28, 2024 Check the appropriate box to designate the rule pur |
|
| March 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2024 EXPONENT, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| February 23, 2024 |
Exponent, Inc. Incentive Compensation Recovery Policy Exhibit 97.01 EXPONENT, INC. 2023 Clawback Policy Effective October 2, 2023 Purpose Asrequired pursuant to the listing standards of the Nasdaq Stock Market LLC (the “Stock Exchange”), Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule 10D-1 under the Exchange Act, the Board of Directors (the “Board”) of Exponent, Inc. (the “Company”) has adopted this 2023 |
|
| February 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 29, 2023. OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONENT, INC. (Exact nam |
|
| February 23, 2024 |
Exhibit 21.1 SUBSIDIARIES OF THE COMPANY State or Other Jurisdiction of Incorporation or Subsidiary Incorporation or Organization Exponent Consulting (Canada) Inc. Canada Exponent Consulting PTE. Ltd. Singapore Exponent International Engineering and Scientific Consulting Limited Ireland Exponent International GmbH Germany Exponent International Ltd. United Kingdom Exponent Limited Hong Kong Expone |
|
| February 23, 2024 |
Certificate of Amendment of Restated Certificate of Incorporation dated January 30, 1998. Exhibit 3.1(ii) STATE OF DELAWARE SECRETARY OF STATE DIVISION OF CORPORATIONS FILED 04:30 PM 01/30/1998 981039836 - 2195846 CERTIFICATE OF AMENDMENT OF RESTATED CERTIFICATE OF INCORPORATION OF THE FAILURE GROUP, INC. THE FAILURE GROUP, INC., a corporation organized and existing under and by virtue of General Corporation Law of the State of Delaware (the "General Corporation Law"). does hereby cert |
|
| February 13, 2024 |
EXPO / Exponent, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0899-exponentinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 13)* Name of issuer: Exponent Inc Title of Class of Securities: Common Stock CUSIP Number: 30214U102 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule |
|
| February 13, 2024 |
EXPO / Exponent, Inc. / KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC Passive Investment SC 13G/A 1 fp0086862-20sc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 2)* EXPONENT INC (Name of Issuer) Common Stock (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2023 (Da |
|
| February 12, 2024 |
EXPO / Exponent, Inc. / Neuberger Berman Group LLC Passive Investment SC 13G/A 1 formsc13ga-02122024080255.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 15)* EXPONENT INC (Name of Issuer) Common (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| February 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 02, 2024 EXPONENT, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| February 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 1, 2024 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| February 1, 2024 |
EXHIBIT 99.2 Exponent Increases Quarterly Dividend Payment from $0.26 to $0.28 per Share for Q1 2024, Increases Stock Repurchase Authorization to $100 Million MENLO PARK, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has raised its quarterly dividend from $0.26 to $0.28 per share of common stock. The quarterly cash dividend of $0 |
|
| February 1, 2024 |
Exponent Reports Fourth Quarter and Fiscal Year 2023 Financial Results EXHIBIT 99.1 Exponent Reports Fourth Quarter and Fiscal Year 2023 Financial Results MENLO PARK, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2023 ended December 29, 2023. “Exponent’s world class team of experts delivered a 7% increase in net revenues in 2023, advising clients across industries with a |
|
| January 23, 2024 |
EXPO / Exponent, Inc. / BlackRock Inc. Passive Investment SC 13G/A 1 us30214u1025012324.txt us30214u1025012324.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 5) EXPONENT INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 30214U102 - (CUSIP Number) December 31, 2023 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to de |
|
| January 10, 2024 |
United States securities and exchange commission logo January 10, 2024 Richard Schlenker, Jr. |
|
| January 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Exponent, Inc. (Name of Issuer) Common Stock, $0.01 Par Value (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh |
|
| November 20, 2023 |
Exponent 149 Commonwealth Drive Menlo Park, CA 94025 telephone 650-326-9400 facsimile 650-326-8072 www. |
|
| November 9, 2023 |
United States securities and exchange commission logo November 9, 2023 Richard Schlenker, Jr. |
|
| November 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 29, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT |
|
| October 30, 2023 |
Exponent 149 Commonwealth Drive Menlo Park, CA 94025 telephone 650-326-9400 facsimile 650-326-8072 www. |
|
| October 26, 2023 |
Exponent Reports Third Quarter of Fiscal Year 2023 Financial Results EXHIBIT 99.1 Exponent Reports Third Quarter of Fiscal Year 2023 Financial Results MENLO PARK, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the third quarter of fiscal year 2023 ended September 29, 2023. “Our third quarter results exemplify the durability of our diversified portfolio, which delivered growth in nearly every industry we s |
|
| October 26, 2023 |
Exponent Declares Regular Quarterly Dividend EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.26 per share of common stock to be paid on December 22, 2023 to all common stockholders of record as of December 8, 2023. Exponent has paid, and expects to continue to pa |
|
| October 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2023 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| October 17, 2023 |
United States securities and exchange commission logo October 17, 2023 Richard Schlenker, Jr. |
|
| October 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 02, 2023 EXPONENT, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| September 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 June 8, 2023 Date of Report (Date of earliest event reported) Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or other jurisdiction of incorporation) (Commi |
|
| August 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC |
|
| July 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2023 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| July 27, 2023 |
Exponent Declares Quarterly Dividend for Q3 2023 EXHIBIT 99.2 Exponent Declares Quarterly Dividend for Q3 2023 MENLO PARK, Calif., July 27, 2023 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.26 per share of common stock to be paid on September 22, 2023, to all common stockholders of record as of September 8, 2023. Exponent has paid, and expects to continu |
|
| July 27, 2023 |
Exponent Reports Second Quarter 2023 Financial Results EXHIBIT 99.1 Exponent Reports Second Quarter 2023 Financial Results MENLO PARK, Calif., July 27, 2023 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter of fiscal year 2023 ended June 30, 2023. “Exponent delivered solid second quarter results, growing revenues before reimbursements by 10% on a year-over-year basis and expanding earnings per dil |
|
| June 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 08, 2023 EXPONENT, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, IN |
|
| April 27, 2023 |
Exponent Declares Regular Quarterly Dividend EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., April 27, 2023 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.26 per share of common stock to be paid on June 23, 2023 to all common stockholders of record as of June 9, 2023. Exponent has paid, and expects to continue to pay, quart |
|
| April 27, 2023 |
Exponent Reports First Quarter 2023 Financial Results EXHIBIT 99.1 Exponent Reports First Quarter 2023 Financial Results MENLO PARK, Calif., April 27, 2023 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2023 ended March 31, 2023. “Exponent had a solid start to the year, growing revenues by over 9% on a year-over-year basis. This is a testament to the strength and resiliency of ou |
|
| April 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2023 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| April 25, 2023 |
2022 AnnualReportDear Fellow Shareholders, In 2022, Exponent succeeded in what it does best: leveraging engineering and scientific excellence to deliver breakthrough insights to clients, beneficial impact to society, and increased value to shareholders. |
|
| April 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| April 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| February 24, 2023 |
Exhibit 21.1 SUBSIDIARIES OF THE COMPANY State or Other Jurisdiction of Incorporation or Subsidiary Incorporation or Organization Exponent Consulting (Canada) Inc. Canada Exponent Consulting PTE. Ltd. Singapore Exponent International Engineering and Scientific Consulting Limited Ireland Exponent International GmbH Germany Exponent International Ltd. United Kingdom Exponent Limited Hong Kong Expone |
|
| February 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 30, 2022. OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONENT, INC. (Exact nam |
|
| February 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 15, 2023 EXPONENT, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| February 14, 2023 |
EXPO / Exponent, Inc. / KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC - NONE Passive Investment SC 13G/A 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* EXPONENT INC (Name of Issuer) Common Stock (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant |
|
| February 10, 2023 |
EXPO / Exponent, Inc. / Neuberger Berman Group LLC - NONE Passive Investment SC 13G/A 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 14)* EXPONENT INC (Name of Issuer) Common (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| February 9, 2023 |
EXPO / Exponent, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0876-exponentinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 12)* Name of issuer: Exponent Inc. Title of Class of Securities: Common Stock CUSIP Number: 30214U102 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule |
|
| February 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2023 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| February 2, 2023 |
Exponent Increases Quarterly Dividend Payment from $0.24 to $0.26 per Share EXHIBIT 99.2 Exponent Increases Quarterly Dividend Payment from $0.24 to $0.26 per Share MENLO PARK, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has raised its quarterly dividend from $0.24 to $0.26 per share of common stock. The quarterly cash dividend of $0.26 per share of common stock is to be paid on March 24, 2023 to all c |
|
| February 2, 2023 |
Exponent Reports Fourth Quarter and Fiscal Year 2022 Financial Results EXHIBIT 99.1 Exponent Reports Fourth Quarter and Fiscal Year 2022 Financial Results MENLO PARK, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2022 ended December 30, 2022. “Exponent concluded 2022 with solid results, reflecting broad-based strength across our diversified portfolio of services. In a yea |
|
| January 26, 2023 |
EXPO / Exponent, Inc. / BlackRock Inc. Passive Investment SC 13G/A 1 us30214u1025012623.txt us30214u1025012623.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 4) EXPONENT INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 30214U102 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to de |
|
| January 20, 2023 |
EXPO / Exponent, Inc. / BlackRock Inc. Passive Investment SC 13G/A 1 us30214u1025012023.txt us30214u1025012023.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 3) EXPONENT INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 30214U102 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to de |
|
| December 19, 2022 |
EXHIBIT 3.1 Amended and Restated Bylaws of Exponent, Inc. (As amended and restated on December 15, 2022) Article I Offices Section 1.1 Registered Office. The registered office of Exponent, Inc. (hereafter called the “Corporation”) in the State of Delaware shall be as determined by the Corporation’s Board of Directors (the “Board”) from time to time. The registered agent of the Corporation at such |
|
| December 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2022 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| November 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT |
|
| October 27, 2022 |
Exponent Reports Third Quarter of Fiscal Year 2022 Financial Results EXHIBIT 99.1 Exponent Reports Third Quarter of Fiscal Year 2022 Financial Results MENLO PARK, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the third quarter of fiscal year 2022 ended September 30, 2022. ?Exponent delivered solid results in the third quarter of 2022, achieving another quarter of year-over-year growth across revenue, EBI |
|
| October 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2022 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| October 27, 2022 |
Exponent Declares Regular Quarterly Dividend EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.24 per share of common stock to be paid on December 23, 2022 to all common stockholders of record as of December 9, 2022. Exponent has paid, and expects to continue to pay |
|
| August 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 1, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC. |
|
| July 28, 2022 |
Exponent Declares Regular Quarterly Dividend EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., July 28, 2022 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.24 per share of common stock to be paid on September 23, 2022 to all common stockholders of record as of September 9, 2022. Exponent has paid, and expects to continue to p |
|
| July 28, 2022 |
Exponent Reports Second Quarter 2022 Financial Results EXHIBIT 99.1 Exponent Reports Second Quarter 2022 Financial Results MENLO PARK, Calif., July 28, 2022 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter of fiscal year 2022 ended July 1, 2022. ?Exponent delivered solid second quarter results, advancing our long-term strategy and reinforcing our strong financial position. Our business model cont |
|
| July 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2022 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| June 3, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2022 Exponent, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 1, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC |
|
| April 28, 2022 |
Exponent Declares Regular Quarterly Dividend EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., April 28, 2022 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.24 per share of common stock to be paid on June 24, 2022 to all common stockholders of record as of June 10, 2022. Exponent has paid, and expects to continue to pay, quar |
|
| April 28, 2022 |
Exponent Reports First Quarter 2022 Financial Results EXHIBIT 99.1 Exponent Reports First Quarter 2022 Financial Results MENLO PARK, Calif., April 28, 2022 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2022 ended April 1, 2022. ?We are pleased to report year-over-year growth in revenue and EBITDA1, once again demonstrating the strength of our business model and our ability to ex |
|
| April 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2022 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| April 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| April 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| February 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2021. OR ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONENT, INC. (Exact nam |
|
| February 25, 2022 |
Exhibit 10.18 Exponent, Inc. Nonqualified Deferred Compensation Plan Adoption Agreement Table of Contents 1.01 Preamble 1 1.02 Plan 1 1.03 Plan Sponsor 1 1.04 Employer 2 1.05 Administrator 2 1.06 Key Employee Determination Dates 2 2.01 Participation 3 3.01 Compensation 4 3.02 Bonuses 5 4.01 Participant Contributions 6 5.01 Employer Contributions 9 6.01 Distributions 12 7.01 Vesting 16 8.01 Unfores |
|
| February 25, 2022 |
Exhibit 21.1 SUBSIDIARIES OF THE COMPANY State or Other Jurisdiction of Incorporation or Subsidiary Incorporation or Organization Exponent Consulting (Canada) Inc. Canada Exponent Consulting PTE. Ltd. Singapore Exponent International Engineering and Scientific Consulting Limited Ireland Exponent International Ltd. United Kingdom Exponent Limited Hong Kong Exponent Realty LLC Delaware Exponent Scie |
|
| February 22, 2022 |
Exponent Increases Share Repurchase Authorization by $150 Million EXHIBIT 99.1 Exponent Increases Share Repurchase Authorization by $150 Million MENLO PARK, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors approved a $150 million expansion of its share repurchase program, adding to the $29.5 million that remains available under the current authorization for repurchases. In total, the Company now ha |
|
| February 22, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 22, 2022 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| February 11, 2022 |
EXPO / Exponent, Inc. / KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC - NONE Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* EXPONENT INC (Name of Issuer) Common Stock (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedul |
|
| February 11, 2022 |
EXPO / Exponent, Inc. / Neuberger Berman Group LLC - NONE Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 13)* EXPONENT INC (Name of Issuer) Common (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is fil |
|
| February 10, 2022 |
EXPO / Exponent, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Exponent Inc. Title of Class of Securities: Common Stock CUSIP Number: 30214U102 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ??Rule |
|
| February 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 3, 2022 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| February 3, 2022 |
Exponent Increases Quarterly Dividend Payment from $0.20 to $0.24 per Share EXHIBIT 99.2 Exponent Increases Quarterly Dividend Payment from $0.20 to $0.24 per Share MENLO PARK, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has raised its quarterly dividend by 20% from $0.20 to $0.24 per share of common stock. The quarterly cash dividend of $0.24 per share of common stock is to be paid on March 25, 2022 to |
|
| February 3, 2022 |
Exponent Reports Fourth Quarter and Fiscal Year 2021 Financial Results EXHIBIT 99.1 Exponent Reports Fourth Quarter and Fiscal Year 2021 Financial Results MENLO PARK, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2021 ended December 31, 2021. ?We finished the year strong, highlighting the exceptional performance of our team and resiliency of our business model. For the fu |
|
| January 27, 2022 |
EXPO / Exponent, Inc. / BlackRock Inc. Passive Investment us30214u1025012622.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) EXPONENT INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 30214U102 - (CUSIP Number) December 31, 2021 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| January 25, 2022 |
EXPO / Exponent, Inc. / BlackRock Inc. Passive Investment us30214u1025012522.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) EXPONENT INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 30214U102 - (CUSIP Number) December 31, 2021 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| November 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 1, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, I |
|
| October 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2021 EXPONENT INC (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| October 28, 2021 |
Exponent Reports Third Quarter of Fiscal Year 2021 Financial Results EXHIBIT 99.1 Exponent Reports Third Quarter of Fiscal Year 2021 Financial Results MENLO PARK, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the third quarter of fiscal year 2021 ended October 1, 2021. ?Our differentiated capabilities, which marry high-quality data analytics with deep subject matter expertise, drove continued outperforma |
|
| October 28, 2021 |
Exponent Declares Regular Quarterly Dividend EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share of common stock to be paid on December 17, 2021 to all common stockholders of record as of December 3, 2021. Exponent has paid, and expects to continue to pay |
|
| August 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 2, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC. |
|
| July 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 29, 2021 EXPONENT INC (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) ( |
|
| July 29, 2021 |
Exponent Declares Regular Quarterly Dividend EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., July 29, 2021 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share of common stock to be paid on September 24, 2021 to all common stockholders of record as of September 10, 2021. Exponent has paid, and expects to continue to |
|
| July 29, 2021 |
Exponent Reports Second Quarter of Fiscal Year 2021 Financial Results EXHIBIT 99.1 Exponent Reports Second Quarter of Fiscal Year 2021 Financial Results MENLO PARK, Calif., July 29, 2021 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter of fiscal year 2021 ended July 2, 2021. ?During the second quarter, we saw broad-based strength across the business as pandemic-related restrictions eased, which supported a robu |
|
| June 7, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2021 Exponent, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 0-018655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 2, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC |
|
| April 29, 2021 |
Exponent Reports First Quarter of Fiscal Year 2021 Financial Results EXHIBIT 99.1 Exponent Reports First Quarter of Fiscal Year 2021 Financial Results MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the first quarter of fiscal year 2021 ended April 2, 2021. ?Our business continued to gain momentum, driving strong quarterly results which exceeded our prior expectations. In the first quarter, net |
|
| April 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2021 EXPONENT INC (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| April 29, 2021 |
Exponent Declares Regular Quarterly Dividend EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share of common stock to be paid on June 25, 2021 to all common stockholders of record as of June 11, 2021. Exponent has paid, and expects to continue to pay, quar |
|
| April 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| February 26, 2021 |
Exhibit 10.38 EXPONENT, INC 401(k) SAVINGS PLAN (As Amended and Restated Effective January 1, 2014) TABLE OF CONTENTS Page ARTICLE I. INTRODUCTION 1 ARTICLE II. DEFINITIONS 2 2.1 Account 2 2.2 Adjustment Factor 2 2.3 Administrator 2 2.4 Beneficiary 2 2.5 Board 2 2.6 Break in Service 2 2.7 Code 2 2.8 Committee 2 2.9 Company 2 2.10 Compensation 2 2.11 Contributions 3 2.12 Disability 3 2.13 Early Ret |
|
| February 26, 2021 |
Exhibit 10.39 FIRST AMENDMENT TO THE EXPONENT, INC. 401(k) SAVINGS PLAN (AS AMENDED AND RESTATED JANUARY 1, 2014) WHEREAS, Exponent, Inc. (the ?Company?) adopted an amended and restated 401(k) Savings Plan effective January 1, 2014 (the "Plan"); and WHEREAS, the Company wishes to amend the Plan in order to reflect the Plan?s compliance with certain requirements of the Internal Revenue Code; and WH |
|
| February 26, 2021 |
Exhibit 21.1 SUBSIDIARIES OF THE COMPANY State or Other Jurisdiction of Incorporation or Subsidiary Incorporation or Organization Exponent Consulting (Canada) Inc. Canada Exponent Consulting PTE. Ltd. Singapore Exponent International Engineering and Scientific Consulting Limited Ireland Exponent International Ltd. United Kingdom Exponent Limited Hong Kong Exponent Realty LLC Delaware Exponent Scie |
|
| February 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended January 1, 2021. OR ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONENT, INC. (Exact name |
|
| February 26, 2021 |
Exhibit 10.40 SECOND AMENDMENT TO THE EXPONENT, INC. 401(k) SAVINGS PLAN (AS AMENDED AND RESTATED JANUARY 1, 2014) WHEREAS, Exponent, Inc. (the ?Company?) adopted an amended and restated 401(k) Savings Plan effective January 1, 2014 (the "Plan"); and WHEREAS, the Company wishes to amend the Plan in order to make certain changes regarding hardship withdrawals; and WHEREAS, the Company retains the r |
|
| February 12, 2021 |
Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 12)* EXPONENT INC (Name of Issuer) Common (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc |
|
| February 10, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: Exponent Inc. Title of Class of Securities: Common Stock CUSIP Number: 30214U102 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule |
|
| February 4, 2021 |
Exponent Increases Quarterly Dividend Payment from $0.19 to $0.20 per Share EX-99.2 3 exh992.htm PRESS RELEASE EXHIBIT 99.2 Exponent Increases Quarterly Dividend Payment from $0.19 to $0.20 per Share MENLO PARK, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared an increased quarterly cash dividend of $0.20 per share of common stock to be paid on March 26, 2021 to all common stockholders of record |
|
| February 4, 2021 |
Exponent Reports Fourth Quarter and Fiscal Year 2020 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports Fourth Quarter and Fiscal Year 2020 Financial Results MENLO PARK, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the fourth quarter and fiscal year 2020 ended January 1, 2021. “In a year of worldwide challenge, we demonstrated the durability of Exponent’s business model and |
|
| February 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 4, 2021 EXPONENT INC (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| January 25, 2021 |
us30214u1025012521.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: ) EXPONENT INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 30214U102 - (CUSIP Number) December 31, 2020 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| December 4, 2020 |
United States securities and exchange commission logo December 4, 2020 Richard Schlenker, Jr. |
|
| December 4, 2020 |
United States securities and exchange commission logo December 4, 2020 Richard Schlenker, Jr. |
|
| November 25, 2020 |
November 25, 2020 VIA EDGAR Mr. Blaise Rhodes Mr. Rufus Decker U.S. Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street, NE Washington, D.C. 20549 Re: Exponent, Inc. Form 10-K for the Fiscal Year Ended January 3, 2020 Filed February 28, 2020 File No. 000-18655 Dear Messrs. Rhodes and Decker: Exponent, Inc., a Delaware corporation (the “Company |
|
| November 17, 2020 |
United States securities and exchange commission logo November 17, 2020 Richard Schlenker, Jr. |
|
| November 17, 2020 |
United States securities and exchange commission logo November 17, 2020 Richard Schlenker, Jr. |
|
| November 6, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 2, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, I |
|
| October 29, 2020 |
Exponent Reports Third Quarter of Fiscal Year 2020 Financial Results EXHIBIT 99.1 Exponent Reports Third Quarter of Fiscal Year 2020 Financial Results MENLO PARK, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the third quarter of fiscal year 2020 ended October 2, 2020. “We are pleased with the improvements that we have seen across our business and believe that our third quarter results demonstrate resilie |
|
| October 29, 2020 |
Exponent Declares Regular Quarterly Dividend EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per share of common stock. The quarterly cash dividend of $0.19 per share of common stock is to be paid on December 18, 2020 to all common stockholders of record as of |
|
| October 29, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2020 EXPONENT INC (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| October 27, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2020 Exponent, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 0-018655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| August 10, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 3, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC. |
|
| July 30, 2020 |
Exponent Reports Second Quarter of Fiscal Year 2020 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports Second Quarter of Fiscal Year 2020 Financial Results MENLO PARK, Calif., July 30, 2020 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the second quarter of fiscal year 2020 ended July 3, 2020. “We are pleased with the responsiveness of our employees and the adaptiveness of our company to today’s |
|
| July 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2020 EXPONENT INC (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) ( |
|
| July 30, 2020 |
Exponent Declares Regular Quarterly Dividend EX-99.2 3 exh992.htm PRESS RELEASE EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., July 30, 2020 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per share of common stock. The Company also announced that the Board of Directors has authorized an additional $45 million for stock |
|
| May 29, 2020 |
Regulation FD Disclosure, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2020 Exponent, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 0-018655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 8, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 3, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC |
|
| May 6, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| April 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2020 EXPONENT INC (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| April 30, 2020 |
Exponent Declares Regular Quarterly Dividend EX-99.2 3 exh992.htm PRESS RELEASE EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., April 30, 2020 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per share of common stock to be paid on June 26, 2020 to all common stockholders of record as of June 12, 2020. Exponent has paid, a |
|
| April 30, 2020 |
Exponent Reports First Quarter of Fiscal Year 2020 Financial Results EXHIBIT 99.1 Exponent Reports First Quarter of Fiscal Year 2020 Financial Results MENLO PARK, Calif., April 30, 2020 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2020 ended April 3, 2020. “We are pleased to report another strong first quarter with year over year growth in revenues and earnings. Business restrictions related |
|
| April 15, 2020 |
EXPO / Exponent, Inc. DEF 14A - - DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| February 28, 2020 |
Exhibit 21.1 SUBSIDIARIES OF THE COMPANY State or Other Jurisdiction of Incorporation or Subsidiary Incorporation or Organization Exponent Consulting PTE. Ltd. Singapore Exponent GmbH Germany Exponent International Engineering and Scientific Consulting Limited Ireland Exponent International Ltd. United Kingdom Exponent Limited Hong Kong Exponent Realty LLC Delaware Exponent Science and Technology |
|
| February 28, 2020 |
Exhibit 4.2 DESCRIPTION OF REGISTRANT’S SECURITIES The following brief description of the capital stock of Exponent, Inc. (“us”, “our”, “we”, or the “Company”), is a summary. This summary is not complete and is subject to and qualified in its entirety by reference to the complete text of our Restated Certificate of Incorporation (“Certificate of Incorporation”) and our Amended and Restated By-Laws |
|
| February 28, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended January 3, 2020. OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONENT, INC. (Exact name |
|
| February 28, 2020 |
First Amendment to the Exponent, Inc. 401(k) Savings Plan (as amended and restated January 1, 2014). Exhibit 10.39 FIRST AMENDMENT TO THE EXPONENT, INC. 401(k) SAVINGS PLAN (AS AMENDED AND RESTATED JANUARY 1, 2014) WHEREAS, Exponent, Inc. (the “Company”) adopted an amended and restated 401(k) Savings Plan effective January 1, 2014 (the "Plan"); and WHEREAS, the Company wishes to amend the Plan in order to reflect the Plan’s compliance with certain requirements of the Internal Revenue Code; and WH |
|
| February 28, 2020 |
Exponent, Inc. 401(k) Savings Plan, as amended and restated effective January 1, 2014. EX-10.38 3 expo-ex1038303.htm EX-10.38 2014 PLAN Exhibit 10.38 EXPONENT, INC 401(k) SAVINGS PLAN (As Amended and Restated Effective January 1, 2014) TABLE OF CONTENTS Page ARTICLE I. INTRODUCTION 1 ARTICLE II. DEFINITIONS 2 2.1 Account 2 2.2 Adjustment Factor 2 2.3 Administrator 2 2.4 Beneficiary 2 2.5 Board 2 2.6 Break in Service 2 2.7 Code 3 2.8 Committee 3 2.9 Company 3 2.10 Compensation 3 2.11 |
|
| February 28, 2020 |
Exhibit 10.40 SECOND AMENDMENT TO THE EXPONENT, INC. 401(k) SAVINGS PLAN (AS AMENDED AND RESTATED JANUARY 1, 2014) WHEREAS, Exponent, Inc. (the “Company”) adopted an amended and restated 401(k) Savings Plan effective January 1, 2014 (the "Plan"); and WHEREAS, the Company wishes to amend the Plan in order to make certain changes regarding hardship withdrawals; and WHEREAS, the Company retains the r |
|
| February 12, 2020 |
EXPO / Exponent, Inc. / Neuberger Berman Group LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 11)* EXPONENT INC (Name of Issuer) Common (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc |
|
| February 12, 2020 |
EXPO / Exponent, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Exponent Inc Title of Class of Securities: Common Stock CUSIP Number: 30214U102 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 1 |
|
| February 6, 2020 |
Exponent Increases Quarterly Dividend Payment from $0.16 to $0.19 per Share EXHIBIT 99.2 Exponent Increases Quarterly Dividend Payment from $0.16 to $0.19 per Share MENLO PARK, Calif., Feb. 06, 2020 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared an increased quarterly cash dividend of $0.19 per share of common stock to be paid on March 27, 2020 to all common stockholders of record as of March 13, 2020. “In 2019, we |
|
| February 6, 2020 |
Exponent Reports Fourth Quarter and Fiscal Year 2019 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports Fourth Quarter and Fiscal Year 2019 Financial Results MENLO PARK, Calif., Feb. 06, 2020 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the fourth quarter and fiscal year 2019 ended January 3, 2020. “The fourth quarter was exceptional and concluded a strong 2019 for Exponent. For the quarter and y |
|
| February 6, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2020 EXPONENT INC (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| February 4, 2020 |
EXPO / Exponent, Inc. / BlackRock Inc. Passive Investment us30214u1025020320.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 11) EXPONENT INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 30214U102 - (CUSIP Number) December 31, 2019 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whic |
|
| January 17, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Exponent, Inc. (Name of Issuer) Common Stock, $0.01 Par Value (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2019 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule i |
|
| November 1, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 27, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT |
|
| October 17, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2019 EXPONENT INC (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| October 17, 2019 |
Exponent Declares Regular Quarterly Dividend EX-99.2 3 exh992.htm PRESS RELEASE EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., Oct. 17, 2019 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.16 per share of common stock to be paid on December 20, 2019 to all common stockholders of record as of December 6, 2019. Exponent has p |
|
| October 17, 2019 |
Exponent Reports Third Quarter of Fiscal Year 2019 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports Third Quarter of Fiscal Year 2019 Financial Results MENLO PARK, Calif., Oct. 17, 2019 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the third quarter of fiscal year 2019 ended September 27, 2019. “Exponent reported high-single digit net revenue growth during the third quarter, representing conti |
|
| August 2, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 28, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC |
|
| July 18, 2019 |
Exponent Reports Second Quarter of Fiscal Year 2019 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports Second Quarter of Fiscal Year 2019 Financial Results MENLO PARK, Calif., July 18, 2019 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the second quarter of fiscal year 2019 ended June 28, 2019. “Exponent delivered strong second quarter results with double digit growth in revenues and profits. As |
|
| July 18, 2019 |
Exponent Declares Regular Quarterly Dividend EX-99.2 3 exh992.htm PRESS RELEASE EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., July 18, 2019 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.16 per share of common stock to be paid on September 20, 2019 to all common stockholders of record as of September 6, 2019. Exponent has |
|
| July 18, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): July 18, 2019 EXPONENT INC (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R. |
|
| June 3, 2019 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 30, 2019 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or other jurisdiction of incorporation) (Commission file numbe |
|
| May 3, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 29, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, IN |
|
| April 18, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): April 18, 2019 Exponent, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I |
|
| April 18, 2019 |
Exponent Reports First Quarter of Fiscal Year 2019 Financial Results EXHIBIT 99.1 Exponent Reports First Quarter of Fiscal Year 2019 Financial Results MENLO PARK, Calif., April 18, 2019 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the first quarter of fiscal year 2019 ended March 29, 2019. “Exponent’s first quarter of 2019 built on its positive momentum from 2018. In line with our prior expectations, we achieved low-single di |
|
| April 18, 2019 |
Exponent Declares Regular Quarterly Dividend EX-99.2 3 exh992.htm PRESS RELEASE EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., April 18, 2019 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.16 per share of common stock to be paid on June 21, 2019 to all common stockholders of record as of June 7, 2019. Exponent has paid, an |
|
| April 16, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) x Definitive Proxy State |
|
| February 22, 2019 |
EXPO / Exponent, Inc. FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 28, 2018. OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONENT, INC. (Exact nam |
|
| February 22, 2019 |
EX-21.1 2 tv512970ex21-1.htm EXHIBIT 21.1 Exhibit 21.1 SUBSIDIARIES OF THE COMPANY State or Other Jurisdiction of Incorporation or Subsidiary Incorporation or Organization Exponent Consulting PTE. Ltd. Singapore Exponent GmbH Germany Exponent International Engineering and Scientific Consulting Limited Ireland Exponent International Ltd. United Kingdom Exponent Limited Hong Kong Exponent Realty LLC |
|
| February 13, 2019 |
EXPO / Exponent, Inc. / Neuberger Berman Group LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10)* EXPONENT INC (Name of Issuer) Common (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc |
|
| February 11, 2019 |
EXPO / Exponent, Inc. / VANGUARD GROUP INC Passive Investment exponentinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8 )* Name of issuer: Exponent Inc Title of Class of Securities: Common Stock CUSIP Number: 30214U102 Date of Event Which Requires Filing of this Statement: December 31, 2018 Check the appropriate box to designat |
|
| January 31, 2019 |
Exponent Reports Fourth Quarter and Fiscal Year 2018 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports Fourth Quarter and Fiscal Year 2018 Financial Results MENLO PARK, Calif., Jan. 31, 2019 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the fourth quarter and fiscal year ended December 28, 2018. “2018 was another year of solid growth for Exponent. We posted high-single digit revenue growth, expan |
|
| January 31, 2019 |
EXHIBIT 99.2 Exponent Increases Quarterly Dividend Payment from $0.13 to $0.16 per Share and Adds $75 Million to Stock Repurchase Authorization MENLO PARK, Calif., Jan. 31, 2019 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that it has raised its quarterly dividend by 23% from $0.13 to $0.16 per share of common stock and has authorized an additional $75 million for stock repurcha |
|
| January 31, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): January 31, 2019 Exponent, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| January 28, 2019 |
EXPO / Exponent, Inc. / BlackRock Inc. Passive Investment us30214u1025012819.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 10) EXPONENT INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 30214U102 - (CUSIP Number) December 31, 2018 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whic |
|
| December 10, 2018 |
EXPO / Exponent, Inc. / VANGUARD GROUP INC Passive Investment exponentinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7 )* Name of issuer: Exponent Inc Title of Class of Securities: Common Stock CUSIP Number: 30214U102 Date of Event Which Requires Filing of this Statement: November 30, 2018 Check the appropriate box to designat |
|
| November 2, 2018 |
EXPO / Exponent, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 28, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT |
|
| October 18, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): October 18, 2018 Exponent, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| October 18, 2018 |
Exponent Declares Regular Quarterly Dividend EX-99.2 3 exh992.htm PRESS RELEASE EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.13 per share of common stock to be paid on December 21, 2018 to all common stockholders of record as of December 7, 2018. Exponent has p |
|
| October 18, 2018 |
Exponent Reports Third Quarter of Fiscal Year 2018 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports Third Quarter of Fiscal Year 2018 Financial Results MENLO PARK, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the third quarter ended September 28, 2018. “Exponent posted high-single digit revenue and EBITDA1 growth reflecting strong demand for our expertise during the thir |
|
| August 3, 2018 |
EXPO / Exponent, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 29, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC |
|
| August 3, 2018 |
Restated Certificate of Incorporation, as amended effective May 31, 2018. Exhibit 3.1 CERTIFICATE OF AMENDMENT OF RESTATED CERTIFICATE OF INCORPORATION OF EXPONENT, INC. Exponent, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify: FIRST: Paragraph (A) of Article Fourth of the Corporation’s Restated Certificate of Incorporation is hereby amended and restated to r |
|
| July 19, 2018 |
Exponent Declares Regular Quarterly Dividend EX-99.2 3 exh992.htm PRESS RELEASE EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., July 19, 2018 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.13 per share of common stock to be paid on September 21, 2018 to all common stockholders of record as of September 7, 2018. Exponent has |
|
| July 19, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): July 19, 2018 Exponent, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I. |
|
| July 19, 2018 |
Exponent Reports Second Quarter of Fiscal Year 2018 Financial Results EXHIBIT 99.1 Exponent Reports Second Quarter of Fiscal Year 2018 Financial Results MENLO PARK, Calif., July 19, 2018 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the second quarter ended June 29, 2018. “Exponent delivered high-single digit revenue growth in the quarter and continued to expand margins, contributing to a strong first half of 2018. Exponent’s r |
|
| May 31, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 31, 2018 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or other jurisdiction of incorporation) (Commission File Number) ( |
|
| May 31, 2018 |
Exponent Announces Two-for-One Stock Split EX-99.2 4 tv495574e99-2.htm EXHIBIT 99.2 Exhibit 99.2 Exponent Announces Two-for-One Stock Split MENLO PARK, Calif., May 31, 2018 Exponent, Inc. (Nasdaq:EXPO) today announced that its stockholders have approved a two-for-one stock split of its common stock and a change in the number of authorized shares of common stock to 120 million. On June 7, 2018, each stockholder of record at the close of bus |
|
| May 31, 2018 |
EX-99.1 3 tv495574e99-1.htm EXHIBIT 99.1 Exhibit 99.1 Exponent Announces Executive Transition Board of Directors appoints Catherine Corrigan as Chief Executive Officer and Paul R. Johnston as Executive Chairman MENLO PARK, CA, May 31, 2018 - Exponent, Inc. (NASDAQ: EXPO) today announced that its Board of Directors appointed Dr. Catherine Corrigan, 49, as its Chief Executive Officer and President, |
|
| May 31, 2018 |
EX-3.1 2 tv495574ex3-1.htm EXHIBIT 3.1 Exhibit 3.1 CERTIFICATE OF AMENDMENT OF RESTATED CERTIFICATE OF INCORPORATION OF EXPONENT, INC. Exponent, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify: FIRST: Paragraph (A) of Article Fourth of the Corporation’s Restated Certificate of Incorporat |
|
| May 15, 2018 |
Exponent Announces Two-for-One Stock Split EXHIBIT 99.1 Exponent Announces Two-for-One Stock Split MENLO PARK, Calif., May 15, 2018 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has approved a two-for-one stock split of its common stock and a change in the number of authorized shares of common stock to 120 million, each subject to stockholder approval of both the split and the change in authori |
|
| May 15, 2018 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): May 15, 2018 Exponent, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R |
|
| May 4, 2018 |
EXPO / Exponent, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 30, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC |
|
| April 19, 2018 |
Exponent Declares Regular Quarterly Dividend EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., April 19, 2018 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.26 per share of common stock to be paid on June 22, 2018 to all common stockholders of record as of June 8, 2018. Exponent has paid, and expects to continue to pay, quart |
|
| April 19, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): April 19, 2018 Exponent, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I |
|
| April 19, 2018 |
Exponent Reports First Quarter of Fiscal Year 2018 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports First Quarter of Fiscal Year 2018 Financial Results MENLO PARK, Calif., April 19, 2018 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the first quarter ended March 30, 2018. “Exponent continued its strong momentum from 2017 into the first quarter of 2018. We delivered double-digit revenue growth |
|
| April 17, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) x Definitive Proxy State |
|
| April 6, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State |
|
| March 19, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 EXPONENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 77-0218904 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 149 Commonwealth Drive, Menlo Park, California 94025 (Address of Principa |
|
| February 23, 2018 |
EXPO / Exponent, Inc. FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 29, 2017. OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONENT, INC. (Exact nam |
|
| February 23, 2018 |
Exhibit 21.1 SUBSIDIARIES OF THE COMPANY State or Other Jurisdiction of Incorporation or Subsidiary Incorporation or Organization Exponent GmbH Germany Exponent International Ltd. United Kingdom Exponent Limited Hong Kong Exponent Realty LLC Delaware Exponent Science and Technology Consulting (Shanghai) Co., Ltd. China |
|
| February 15, 2018 |
EXPO / Exponent, Inc. / Neuberger Berman Group LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 9)* EXPONENT INC (Name of Issuer) Common (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch |
|
| February 9, 2018 |
EXPO / Exponent, Inc. / VANGUARD GROUP INC Passive Investment exponentinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6 )* Name of issuer: Exponent Inc Title of Class of Securities: Common Stock CUSIP Number: 30214U102 Date of Event Which Requires Filing of this Statement: December 31, 2017 Check the appropriate box to designat |
|
| February 1, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): February 1, 2018 Exponent, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) |